Baxter International (BAX) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0718131099

(NYSE:BAX Stock) Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Baxter International (BAX) - Stock & Dividends

BAX Stock Overview

Market Cap in USD 20,547m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1981-10-27

BAX Stock Ratings

Fundamental -1.59
Dividend 7.11
Growth 5y -3.87
Rel. Performance vs Sector -0.65
Analysts 3.69
Fair Price Total Ret. 40.19
Fair Price DCF 36.67

BAX Dividends

Yield 12m 2.78%
Yield on Cost 5y 1.69%
Dividends CAGR 5y 6.42%
Payout Consistency 94.3%

BAX Growth Ratios

Growth 12m 5.67%
Growth Correlation 12m -23%
Growth Correlation 3m 65%
CAGR 5y -9.48%
CAGR / Mean Drawdown -0.42
Sharpe Ratio 12m 0.02
Alpha vs SP500 12m -10.08
Beta vs SP500 5y weekly 0.50
CAPM 6.60%
Average Daily Range 2m 2.47%
Regime Oscillator 88.15
Volatility GJR Garch 1y 27.85%
Price / SMA 50 7.16%
Price / SMA 200 5.67%
Current Volume 5002.8k
Average Volume 20d 3780.4k
What is the price of BAX stocks?
As of February 21, 2024, the stock is trading at USD 41.77 with a total of 5,002,790 shares traded.
Over the past week, the price has changed by +5.43%, over one month by +8.21%, over three months by +18.21% and over the past year by +5.67%.
Why is BAX stock down?
Check with which Index or Commodity BAX has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return BAX Return S&P 500
1 Month 8.21% 2.97%
3 Months 18.21% 9.80%
12 Months 5.67% 26.37%
What is the forecast for BAX stock price target?
According to ValueRays Forecast Model, BAX Baxter International will be worth about 43.5 in February 2025.
Issuer Forecast Upside
Wallstreet Target Price 44.3 5.9%
Analysts Target Price 47.1 12.7%
ValueRay Target Price 43.5 4.2%